Oncogenic mutation of nuclear transcription factors often is associated with altered patterns of subcellular localization that may be of functional importance. The leukemogenic transcription factor gene E2A-PBX1 is created through fusion of the genes E2A and PBX1 as a result of t(1;19) in acute lymphoblastic leukemia. We evaluated subcellular localization patterns of E2A-PBX1 protein in transfected cells using immuno¯uorescence. Full-length E2A-PBX1 was exclusively nuclear and was concentrated in spherical domains denoted chimeric-E2A oncoprotein domains (CODs). In contrast, nuclear uorescence for wild-type E2A or PBX1 proteins was diuse. Enhanced concentrations of RNA polymerase II within many CODs and the requirement for an E2A-encoded activation domain suggested transcriptional relevance. However, in situ co-detection of nascent transcripts labeled with bromouridine failed to con®rm altered transcriptional activity in relation to CODs. CODs also failed to co-localize with other proteins known to occupy functional nuclear compartments, including the transcription factor PML, the spliceosome-associated protein SC-35 and the adenovirus replication factor DBP, or with foci of DNA replication. Co-transfection of Hoxb7, a homeodomain protein capable of enhancing DNA binding by PBX1, impaired COD formation, suggesting that CODs contain E2A-PBX1 protein not associated with DNA. We conclude that, as a`gain of function' phenomenon requiring protein elements from both E2A and PBX1, COD formation may be relevant to the biology of E2A-PBX1 in leukemogenesis.
Introduction
The non-random association of particular chromosomal translocations with particular types of leukemia strongly suggests a causal relationship. Moreover, molecular cloning of chromosomal translocation breakpoints has frequently uncovered cellular genes whose functions are deranged as a result of structural changes or altered levels of expression brought about by the translocation. Most oncogenes uncovered through their proximity to chromosomal breakpoints are proposed to function as transcription factors (Cleary, 1992) . Therefore, the study of leukemogenesis has become intimately related to the study of the regulation of gene expression at the transcriptional level.
Two dierent translocations in acute lymphoblastic leukemias involve the E2A gene. The t(1;19) is associated consistently but not exclusively with the pre-B cell subtype of ALL (Pui et al., 1990; Borowitz, 1992; Carroll et al., 1984; Crist et al., 1990) whereas the t(17;19) is observed in a small subgroup of precursor B lineage ALL (Hunger et al., 1994b) . The E2A gene codes for proteins that are members of an extended family of transcription factors de®ned by the presence of a basic helix ± loop ± helix (bHLH) motif (Murre et al., 1994) . The t(1;19) translocation fuses E2A with the PBX1 gene, which encodes a divergent member of an even larger family of transcriptional proteins de®ned by the highly conserved homeodomain motif (Mellentin et al., 1989; Nourse et al., 1990; Kamps et al., 1990; Laughon, 1991) . Fusion of E2A and PBX1 leads to production of chimeric transcription factors incorporating amino-terminal elements encoded by E2A and carboxyl-terminal elements, including the homeodomain, encoded by PBX1. The second translocation, t(17;19), fuses E2A with the HLF gene. HLF codes for a new member of the basic-leucine zipper (bZIP) family of transcriptional proteins (Hunger et al., 1992; Inaba et al., 1992) . In chimeric E2A-HLF proteins, the bHLH motifs of E2A are replaced by elements encoded by HLF, including the bZIP domain.
Both E2A-PBX1 and E2A-HLF display potent transcriptional activation potential (van Dijk et al., 1993; LeBrun and Cleary, 1994; Lu et al., 1994; Hunger et al., 1994a; Inaba et al., 1994) . Furthermore, this transcriptional activity correlates with the ability of these proteins to induce neoplastic transformation in experimental assays (Monica et al., 1994; Yoshihara et al., 1995) . These ®ndings serve to emphasize further the importance of abnormal transcriptional regulation in leukemogenesis.
Transcription factors involved in oncogenic chromosomal translocations often assume non-homogeneous patterns of intranuclear localization. For example, PML-RARa, PLZF-RARa, CBF-MYH11, related to t(15; 17), t(11; 17) , inv(16), t(6;9) and t(8;14), respectively, are all concentrated within discrete nuclear foci (Dyck et al., 1994; Reid et al., 1995; Wijmenga et al., 1996; Fornerod et al., 1995; Spector et al., 1987) . These observations, in conjunction with the growing realization that the cell nucleus is highly compartmentalized with respect to structure and function, have stimulated interest in the potential biological relevance of these visually-striking localization patterns.
In this study, we sought to determine whether the alterations in transcriptional or transforming properties that result from acquisition of E2A-derived elements by chimeric oncoproteins E2A-PBX1 or E2A-HLF may be re¯ected in altered subcellular distributions. We report that, while the protein products of the untranslocated genes E2A, PBX1 or HLF are distributed diusely, E2A-PBX1 and E2A-HLF are concentrated within spherical intranuclear domains that appear to contain non-DNA binding forms of these chimeric proteins.
Results
Chimeric E2A-PBX1 proteins, but not the constituent wild-type proteins E2A or PBX1, are concentrated in spherical intranuclear domains
The subcellular localization of E2A-PBX1 was investigated in COS-7 cells transiently transfected with a plasmid expressing complementary DNA (cDNA) under the control of a human CMV promoter. Transfected proteins were detected by immunofluorescence using a monoclonal antibody directed against the E2A-derived portion of the chimeric protein (Jacobs et al., 1993) or an antiserum directed speci®cally against the alternatively spliced carboxyl terminus of PBX1a (Monica et al., 1991) . Identical¯uorescence patterns for E2A-PBX1a were observed using either reagent. In untransfected COS cells, immuno¯uorescence staining for E2A was exclusively nuclear, spared nucleoli and associated with a ®nely granular distribution. No distinct, spherical structures were visible. With the anti-PBX1a antiserum, untransfected cells were associated with very weak nuclear¯uorescence of uncertain signi®cance. Transfected cells displayed one of several distribution patterns for E2A-PBX1a. In the most prevalent pattern, seen in at least 80% of transfected cells,¯uorescence was exclusively intranuclear and was most intense within circular`speckles' or domains distributed apparently randomly within nuclei and appearing against a less intense background of diuse nuclear¯uorescence ( Figure 1a) . These domains, which we shall refer to as CODs (chimeric-E2A oncoprotein domains), numbered from 12 to several hundred. Their size varied from nucleus to nucleus but tended to be quite uniform within individual nuclei. In occasional nuclei, relatively large CODs were visible against a ®eld of coarsely granular nuclear¯uorescence (Figure 1b) . The size of CODs tended to vary in inverse proportion to their numbers and the larger CODs tended to display diminished¯uorescence centrally, giving the impression of hollow centres. In a small proportion of cells nuclear¯uorescence was observed as large, coalescent patches or curvilinear ripples (data not shown). Cells that had undergone nuclear dissolution associated with mitosis exhibited diuse, cytoplasmic uorescence against which condensed chromosomes were sometimes apparent as regions of diminished uorescence (data not shown). E2A-PBX1b, which results from alternative splicing of the PBX1 portion of the chimeric transcript and diverges from PBX1a carboxy-terminal to the homeodomain, was localized to CODs that tended to be larger with more prominent central clearing than those seen on E2A-PBX1a detection (data not shown).
Analysis of cells transfected with a cDNA encoding the wild-type E2A gene product E12 showed an exclusively nuclear pattern of¯uorescence and cells transfected with full-length wild-type PBX1a showed nuclear and cytoplasmic¯uorescence of roughly equal intensities ( Figure 1c and d, respectively) . Signi®cantly, no CODs were visible in cells transfected with constructs encoding either of these wild-type proteins in spite of the fact that they were expressed at levels comparable to the chimeric E2A proteins. Immunolocalization of E2A-PBX1a or PBX1a tagged with the hemagglutinin epitope of in¯uenza virus using an antihemagglutinin monoclonal antibody showed fluorescence patterns similar to those obtained using untagged proteins, further con®rming that CODs were not artifacts produced by particular primary antibodies (data not shown).
The three dimensional distribution and shape of E2A-PBX1a CODs were investigated using confocal laser scanning microscopy ( Figure 2 ). Serial optical sections con®rmed that the structures were spherical, distributed evenly throughout the nuclear volume, and varied in diameter from 0.6 to 3.0 microns. Their apparent hollowness was enhanced on confocal microscopy.
In order to rule out the possibility that CODs resulted from gross overabundance of transfected proteins in COS cells or from replication of the pCMV1 expression plasmids containing the SV-40 origin of replication, transfections were carried out in NIH3T3 (®broblasts), CV1 (epithelial) or REH (lymphoid) cells that lack SV-40 large T antigen necessary for plasmid replication. As in COS cells, E2A-PBX1a was localized to CODs. In order to rule out the possibility that CODs may have resulted from disruption of nuclear structure resulting from transient transfection per se, a stably-transfected cell line was established by transfecting NIH3T3 cells with E2A-PBX1b using the plasmid vector Rc/RSV and selecting for stable transfectants using the drug G418. CODs were clearly visible in the nuclei of some transfected cells, although they appeared smaller and less numerous than those seen in transiently transfected cells and were visible in a smaller proportion of cells (data not shown).
Chimeric E2A-HLF, but not wild-type HLF, is also concentrated in COD-like nuclear domains
The t(17;19)-associated chimera E2A-HLF contains a portion of E2A that is identical to that present in E2A-PBX1. E2A-HLF, however, contains the basic and leucine zipper motifs encoded by HLF and, as a result, binds and activates transcription through a distinctly dierent DNA element (Hunger et al., 1992; Hunger et al., 1994a; Inaba et al., 1994) . Analysis of cells transfected with an E2A-HLF expressing construct showed that it also was localized to large, spherical structures, often with hollow centres, somewhat resembling those seen with E2A-PBX1b (Figure 3a) . In contrast, wild-type HLF, detected by means of an epitope tag, showed exclusively nuclear staining that was distributed diusely (Figure 3b ). Thus, replacement of the bHLH motifs in E12 by heterologous elements in either of the translocation-associated E2A chimeras resulted in a similar alteration in subnuclear localization to new cytologically characteristic sites, i.e. CODs.
CODs colocalize with focal concentrations of RNA polymerase II
The ability of E2A-PBX1 to function as a potent activator of transcription prompted experiments to assess its potential localization to nuclear sites of active transcription or pre-mRNA splicing. In cells transfected with pCMV1 vector alone, immunodetection of RNA polymerase II (Pol II) displayed a diuse pattern of nuclear¯uorescence upon which occasional, small, indistinct speckles were superimposed (data not shown). However, in many cells expressing transfected E2A-PBX1a, Pol II was concentrated within brightlyuorescent foci that co-localized with CODs containing E2A-PBX1a on two-color immuno¯uorescence analysis ( Figure 4a and b). This altered distribution of Pol II suggested that CODs were sites of active transcription associated with the chimeric protein.
Since the antibody used to detect Pol II may not distinguish between active and inactive forms of the enzyme, we sought to con®rm by other means the possibility that E2A-PBX1 localizes to sites of active transcription. SC-35 is a non-snRNP protein involved in pre-mRNA splicing that is concentrated within nuclear domains, called`interchromatin granules', the distribution of which is related to sites of active transcription (Carter et al., 1993; Xing et al., 1993) . Two-color immunodetection failed to demonstrate colocalization of SC-35 with E2A-PBX1 (Figure 4c and d). In order to more directly evaluate the topographical relationship between E2A-PBX1 and transcription, nascent transcripts were labeled with bromouridine (BrU) and detected by immuno¯uorescence. As described previously, nascent transcripts initially are distributed within small speckles scattered throughout the nucleus (Wansink et al., 1993) . These multiply and coalesce over time, giving rise to a granular pattern of nuclear¯uorescence. More coarsely granular signals related to Pol I-dependent transcription develop in nucleoli more gradually. Two-color detection failed to uncover any discernible topographical relationship between E2A-PBX1b CODs and accumulations of nascent transcripts (Figure 4e and f).
In cells infected with adenovirus, macromolecules involved in transcription or replication of viral DNA are distributed in spherical or curvilinear regions, called replication domains, that bear at least a super®cial resemblance to CODs (Bridge et al., 1995) . Therefore, adenovirus-infected cells were used as a model to further investigate a possible relationship between CODs and transcription or DNA replication. COS-7 cells transfected with E2A-PBX1b were infected with adenovirus type 2 and viral domains were demonstrated using a monoclonal antibody against Although the viral domains were demonstrated clearly, no co-localization with the E2A-PBX1-related structures was evident (Figure 4g and h) . Interestingly, CODs and viral replication domains rarely co-existed in nuclei. More often, the nuclei of cells infected with adenovirus and transfected with E2A-PBX1 contained viral replication domains in association with diusē uorescence for E2A-PBX1. Since replication of chromosomal DNA also occurs initially in discrete nuclear domains, the distribution of CODs was compared with that of endogenous replication domains labeled with bromodeoxyuridine (BrdU) and detected with a monoclonal antibody. Most cells that contained CODs failed to incorporate BrdU, indicating that they were not in S-phase (Figure 4i and j) . This ruled out the possibility of a requirement for DNA replication in COD formation.
The putative transcription factor gene PML, which is fused to a portion of the retinoid receptor gene RARa following t(15;17) in acute promyelocytic leukemias, has been shown to encode a protein with a non-uniform nuclear distribution. Wild-type PML has been localized to distinctive nuclear speckles referred to as PML oncogenic domains (PODs) (Dyck et al., 1994; Weis et al., 1994) . It was therefore of interest to determine whether sites of E2A-PBX1 subnuclear localization might correspond to PODs. Two-color immuno¯uorescence analysis using an anti-PML antiserum showed well-de®ned PODs in COS-7 cells transfected with an E2A-PBX1 construct or control plasmids. However, there was no co-localiza- Figure 4 Co-localization studies using two-color immuno¯uorescence. The intracellular distribution of E2A-PBX1 is shown on the left in each pair of images. In many cells, E2A-PBX1a (a) co-localizes with focal concentrations of endogenously-produced RNA polymerase II (b). In contrast, no clear topographical relationship is observed between E2A-PBX1a and the endogenous, spliceosome-associated protein SC-35 (d). Co-detection of E2A-PBX1a (e) with nascent transcripts labeled with bromouridine (f) fails to demonstrate accelerated transcription in relation to CODs. Note that only the upper cell in (f) was transfected. Infection of COS-7 cells with adenovirus type 2 followed by immunodetection of virus-encoded DBP demonstrates viral replication domains in most infected cells (note cell at the bottom of image (h). However, in many cells that both express transfected E2A-PBX1b (g) and were infected with adenovirus, viral replication domains are not formed despite the presence of detectable DBP (h). Most cells expressing transfected E2A-PBX1b (i) fail to incorporate BrdU (j), indicating that they are not in S-phase of the cell cycle. On cotransfection of E2A-PBX1b (k) and Hoxb7 (l), cells singly-transfected with E2A-PBX1b contain well-formed CODs (uppermost cell in k), whereas cells doubly-transfected with E2A-PBX1b and Hoxb7 contain no visible CODs tion of E2A-PBX1 with PML-containing PODs, most of which were smaller and more irregularly shaped than CODs (data not shown).
A transcriptional activation domain from E2A, but not the DNA binding domain from PBX1, is necessary for localization of E2A-PBX1 within CODs Recent studies have shown that acquisition of E2A-encoded protein elements following t(1;19) converts PBX1 into a potent activator of transcription in experimental systems van Dijk et al., 1993; Lu et al., 1994) . Furthermore, domains derived from E2A that are important for transcriptional activation are also required for neoplastic transformation by E2A-PBX1 (Monica et al., 1994; Kamps et al., 1996) . The required portions of E2A correspond to transcriptional activation motifs AD1 and AD2 which have been lozalized to its amino terminus and a conserved loop ± helix motif further carboxy terminal, respectively (Aronheim et al., 1993; Quong et al., 1993) .
The role of speci®c domains of E2A in specifying the subnuclear localization of E2A-PBX1 to CODs was assessed using deletion mutants ( Figure 5 ). Mutants lacking most or all of AD1 (D1 ± 136 and D1 ± 267) showed no localization to CODs. In contrast, a mutant with deletion of the loop ± helix portion of AD2 (D310 ± 414) retained an ability to localize to CODs. These ®ndings indicated that AD1 and not AD2 was critically important for both the localization and transcriptional properties of E2A-PBX1 suggesting a potential linkage of the two phenomena.
A similar deletional analysis was conducted on the PBX1-derived portion of E2A-PBX1a. A mutant lacking all of the PBX1 portion of the chimera (D478 ± 819) failed to form CODs indicating that some portion of PBX1 was required. The PBX1 homeodomain was not necessary for localization to CODs (Figure 5 ), similar to its dispensibility for transformation as reported earlier (Monica et al., 1994; Chang et al., 1997) . A mutant (D477 ± 620,708 ± 819) containing only the PBX1 homeodomain and 25 C-terminal anking amino acids fused to E2A, did not localize to CODs in contrast with the ability of this particular mutant to activate transcription and also induce foci in monolayers of NIH3T3 cells (Monica et al., 1994; Chang et al., 1997) . The contribution of PBX was not contained in a single region of the protein as two nonoverlapping PBX mutations (D621 ± 819 and D477 ± 620) preserved the ability of the chimera to localize to CODs ( Figure 5 ). Taken together, the PBX mutation data were consistent with a model in which CODs resulted from the covalent linkage of disparate E2A and PBX protein motifs as a result of chromosomal translocation. Furthermore, the observation that no particular region of PBX1 is required for COD formation suggests a crucial role for E2A, in particular the AD1 region, in determining the intranuclear localization patterns of the chimeric proteins.
COD formation in transfected cells raised the question of whether similar structures would be visible in translocation-associated cells producing endogenous chimeric E2A protein. Cytospin preparations from the t(1;19)-associated leukemic cell line RCH ACV were immunostained using the Yae mAb. This resulted in Figure 5 Structural analysis of protein segments required for localization of E2A-PBX1a to CODs. A schematic representation of each transfected protein is shown on the left along with a notation of the deleted amino acids. Functionally-de®ned motifs are indicated. Abbreviations or symbols used: 0, CODs absent; +, CODs present; N+C, nuclear and cytoplasmic; N, nuclear granular nuclear¯uorescence exclusive of nucleoli, but no distinct spheres were visible. Since superimposed staining of co-expressed, wild-type E2A proteins could have obscured CODs, the same cells were stained using the antiserum against PBX1a, which is not expressed in lymphoid cells. This resulted in no discernable staining beyond apparent, nonspeci®c background¯uorescence. Therefore, these experiments failed to resolve the issue of COD formation by endogenous chimeric proteins.
COD formation is inhibited by co-expression of Hoxb7, a homeodomain protein capable of co-operative DNA binding with PBX1
The ®nding that deletion from E2A-PBX1 of the homeodomain and all carboxy-terminal peptide elements did not impair COD formation raised the possibility that CODs contain E2A-PBX1 molecules that are not associated with DNA. To test this hypothesis, E2A-PBX1b was co-transfected with a construct expressing Hoxb7, a homeodomain protein known to bind DNA in cooperation with PBX proteins (Knoep¯er and Kamps, 1995; Chang et al., 1995) . The presence of co-transfected Hoxb7 markedly inhibited COD formation by E2A-PBX1b (Figure 4k and l). Cotransfected HLF, which is not expected to interact with E2A-PBX1b, had no apparent eect on COD formation (data not shown). Since Hoxb7 can enhance the ability of E2A-PBX1 to bind DNA, these results support the notion that CODs are occupied by E2A-PBX1 protein that is not bound to DNA. Suppression of their formation by co-transfected Hoxb7 likely resulted from formation of DNA-binding competent E2A-PBX/Hoxb7 complexes eectively reducing the levels of non-DNA bound E2A-PBX available for localization in CODs. These data further suggested that CODs may be storage sites for excess or underutilized transcriptional components.
Discussion
Our studies demonstrate that chimeric oncoproteins E2A-PBX1 and E2A-HLF are distributed in spherical nuclear domains (CODs) following expression in transfected cells. In exploring the functional relevance of CODs we attempted to correlate them to known structures or domains that reside within the cell nucleus. Considerable evidence indicates that the nucleus, far from being a homogenous compartment, is highly organized with respect to function and space. DNA replication, Pol II-mediated transcription, and pre-mRNA processing have all been shown to occur in distinct, although dynamic, nuclear domains (Spector, 1993) . In particular, subcellular detection of polyadenylated mRNA by in situ hybridization produces a signal distribution characterized by numerous intranuclear speckles, termed`transcript domains'. These have been shown to colocalize with speckles produced on immunodetection of small nuclear ribonuclear protein (snRNP) particles involved in pre-mRNA splicing (Nyman et al., 1986; Spector, 1984; Verheijen et al., 1986; Reuter et al., 1984; Carter et al., 1991; Carme-Fonseca et al., 1992) . Splicing and other RNA processing components may also be distributed at lower concentration diusely throughout the nucleoplasm exclusive of nucleoli. Accumulation of molecules associated with pre-mRNA processing at particular subnuclear locations appears to represent a dynamic process in which these molecules are recruited to sites of active transcription (Spector et al., 1983; CarmoFonseca et al., 1992; Jimenez-Garcia and Spector, 1993) .
Based largely on these considerations and the observation that both E2A-PBX1 and E2A-HLF can function as transcriptional activators, we hypothesized that CODs may represent abnormal domains associated with particularly abundant transcriptional activity analogous to those described in adenovirusinfected cells (Bridge et al., 1995) . This possibility seemed to be supported by the requirement for the AD1 transcriptional activation domain in COD formation and co-localization of Pol II with many, although not all, CODs. While additional experiments did not con®rm a direct relationship between CODs and Pol II-dependent transcription, neither did they rule out this possibility. For example, although we could detect no obvious topographical relationship between CODs and SC-35, a protein involved in premRNA splicing, interchromatin granules de®ned by SC-35 accumulations are not necessarily superimposed on transcription domains but may reside adjacent to them (Carter et al., 1993; Xing et al., 1993) . A relationship of this nature may have been missed in our analysis. Furthermore, although direct detection in situ of nascent transcripts labeled with bromouridine failed to reveal enhanced transcription in relation to CODs, this analysis, which evaluated the intranuclear distribution of all nascent transcripts, could not rule out the possibility that an important subset of transcripts is produced more rapidly in these regions. Therefore, the potential relevance of CODs to Pol IImediated transcription remains uncertain.
Additional studies showed no relationship between CODs and DNA replication domains. CODs did not co-localize with in situ foci of BrdU labeling, nor with adenovirus replication domains, as demonstrated by immuno¯uorescence for the adenovirus DNA binding protein DBP. In fact, CODs were seen very rarely in cells that had incorporated BrdU, suggesting that their formation may be restricted to phases of the cell cycle other than S-phase. Finally, we observed no relationship between CODs and the leukemia-related nuclear structures known as PODs, as detected using immunouorescence for the transcription factor PML. These results suggest that CODs may represent a novel nuclear structure of unknown function.
One possibility is that CODs may serve in part as storage sites for excess or under-utilized transcriptional components. Since CODs colocalized with RNA pol II but not splicing components or active transcription domains, they could be depots for inactive Pol II. Furthermore, CODs were not dependent on the DNA binding capacity of E2A-PBX1 and, in fact, were abrogated by maneuvers that provided partners that enhanced the DNA binding capabilities of E2A-PBX1 (e.g. Hoxb7). However, it is unclear why, if CODs are storage sites, their formation is a feature of E2A chimeric proteins and not the respective wild-type E2A, PBX and HLF proteins expressed at comparable levels. Our structure/function analyses indicated that COD formation is strictly dependent on the AD1 domain of E2A but only when removed from its normal context and covalently linked to heterologous sequences. AD1 is also required for both transcriptional activation and neoplastic transformation by E2A-PBX1 or E2A-HLF (Monica et al., 1994; Yoshihara et al., 1995; Kamps et al., 1996) . In contrast, the PBX1 contribution to COD formation can be replaced by an entirely heterologous protein segment encoded by HLF. Furthermore, nonoverlapping portions of PBX1 in constructs D621 ± 819 and D477 ± 620 are capable of supporting COD formation. These observations are consistent with the possibility that PBX1 or HLF could support COD formation through means other than interactions with speci®c proteins or DNA sequences. For instance, these c-terminal additions could serve more general functions such as aecting protein conformation or stability or enhancing nuclear localization. However, it is apparent that COD formation is a gain-of-function and constitutes a unique feature of E2A chimeric proteins.
Although we were unable to detect structures resembling CODs in a t(1;19)-bearing cell line expressing endogenous E2A-PBX1, this likely resulted from limitations of our reagents. Fluorescence related to endogenous CODs may have been obscured by superimposed, diuse or ®nely-granular signal from wild-type E2A proteins that are present in these cells and not expected to localize to CODs based on our results with transfected E12 and in untransfected COS-7 cells expressing endogenous E2A proteins. Moreover, the polyclonal antiserum against PBX1a appears to lack sucient sensitivity to detect the small amount of chimeric protein likely to be present. A recent publication in which E2A-PBX1 protein is detected in translocated 697 cells by immuno¯uorescence using a polyclonal antiserum directed speci®cally against a peptide sequence spanning the fusion point on the molecule did not describe distinct COD-like structures (Berendes et al., 1995) . However, the distribution of the nuclear signal observed in this study was coarsely granular, consistent with the possibility that equivalent structures may have been present but were too small to be recognized using standard optical microscopy. Relevant to this issue is our observation that the size and number of CODs may be related to the intranuclear concentration of E2A-PBX1 protein.
Thus, CODs seen in stably-transfected NIH3T3 ®broblasts were smaller and less numerous than those in transiently-transfected cells, in which the nuclear uorescence signal was more intense and transfected protein more abundant. Furthermore, the possibility exists that at lower levels of expression or in lymphoid cells, CODs exist exclusively under particular conditions of growth or dierentiation.
While our results shed little direct light on mechanisms of neoplastic transformation by E2A-PBX1 or E2A-HLF, several features of COD formation parallel those of neoplastic transformation. AD1 is required both for transformation by either E2A-PBX1 or E2A-HLF and COD formation by E2A-PBX1. AD2 is dispensable for COD formation and may be unnecessary for neoplastic transformation by E2A-PBX1 (Kamps et al., 1996) . As with COD formation, replacement of the carboxyl terminus of E2A proteins by either PBX1-or HLF-encoded elements can support neoplastic transformation. With respect to the PBX1 component, Kamps et al. have reported that a construct that diers from our D621 ± 819 by a single amino acid is transforming in NIH3T3 cells (Kamps et al., 1996) . Therefore, although this ®nding is controversial, the possibility exists that nonoverlapping portions of PBX1 can support not only COD formation but neoplastic transformation. Finally, we have provided suggestive evidence that COD formation is inhibited by maneuvers that enhance DNA binding by E2A-PBX1. Similarly, mutations that impair DNA binding by the PBX1 homeodomain have been reported to result in enhanced transforming potential in NIH3T3 cells (Kamps et al., 1996) .
A popular model of E2A-chimeric oncoprotein leukemogenesis argues that these proteins home to cis-acting regulatory elements of crucial target genes that are normally regulated by PBX or related proteins. Abnormal transcriptional activation is then stimulated by the E2A-encoded activation domains. The ®nding that deletion or mutation of the known DNA binding domains of E2A-PBX1 or E2A-HLF appears not to impair neoplastic transformation by these proteins has revealed this model to be simplistic at best (Monica et al., 1994; Kamps et al., 1996; Inukai et al., 1996) . As stated above, we have not proven a direct link between COD formation and leukemia. However, our observations support the contention that study of altered patterns of subcellular localization associated with chimeric-E2A oncoproteins may provide an additional avenue for investigation of the still unresolved question of how these proteins bring about neoplastic transformation.
Materials and methods

Expression constructs
For transient transfections, complementary DNAs were cloned downstream of the CMV promoter in the expression plasmid pCMV1. The construction of E2A-PBX1a deletion mutants has been described previously (Monica et al., 1994) . Carboxy-terminal tagging of HLF and aminoterminal tagging of Hoxb7 with the`¯ag' epitope, and of PBX1a and E2A-PBX1a with the hemagglutinin epitope, were accomplished using polymerase chain reaction mutagenesis and standard cloning techniques.
Transfections and viral infections
Transient transfections of cultured monkey kidney (COS-7 or CV1) or mouse ®broblast (NIH3T3) cells were performed by calcium phosphate coprecipitation of DNA. On the day prior to transfection, exponentially-growing cells were plated to sub-con¯uence on 2 well chamber slides (Nunc Inc., Naperville, Illinois) in 1 ml of complete culture medium (DME with 10% fetal calf serum). On the day of transfection, DNA mixtures were prepared so as to contain 1.5 mg of expression plasmid and the total DNA content was adjusted to 6 mg with Bluescript DNA. The volume was adjusted to 90 ml with distilled water and 12 ml of 2 M CaCl 2 was added. This solution was added dropwise to 100 ml of ice-cold 26HEPES-buered saline (HEPES 42 mM, NaCl 275 mM, KCl 10 mM, Na 2 HPO 4 1.8 mM, pH 7.15) and incubated on ice for 15 min. One hundred microlitres of this mixture was added, dropwise, to the culture medium containing the cells, followed immediately by 8 ml of 10 mM chloroquine phosphate to enhance transfection eciency. The culture medium was replaced on day 2 and the cells subjected to immunostaining for transfected protein on day 3. Transient transfection of COS-7 cells in some of the co-localization experiments was performed by electroporation as follows. The cells were trypsinized and 4610 6 cells were placed in a cuvette (gap 0.4 cm) in 0.4 ml of complete culture medium containing 20 mg of expression construct DNA. The cells were then subjected to a pulse of electrical current (220 V, 1050 mF) using a Gene Pulser II electroporator from Biorad. For constructs transfected by either method, the method used had no eect on the subcellular localization pattern.
In adenovirus infections, cell lysate containing infectious particles of adenovirus type 2 was added at a multiplicity of 5 to COS-7 cells that had been transfected with E2A-PBX1b roughly 24 h previously and growing in DMEM containing 2% fetal bovine serum. Cells were ®xed for immunofluorescence 24 h after infection.
Immuno¯uorescence
Cells adhering to microscope slides were washed in phosphate-buered saline (PBS), then immersed in 3.7% formaldehyde in PBS for 15 min. Following ®xation, slides were washed then immersed for 30 min in a solution containing 3% BSA and 0.5% triton X-100 in PBS to permeabilize cell membranes and block nonspeci®c antibody binding. The slides were then incubated for 45 min with primary antibodies diluted in blocking solution as follows: anti-PBX1a antiserum, 1 : 100; Yae mAb (provided by Dr Yacop Jacobs or purchased from Santa Cruz Biotechnology, Santa Cruz, California), 1 : 100; anti-human E12/E47 mAb (PharMingen, San Diego, California), 1 : 50; anti-E47 antiserum (Santa Cruz Biotechnology), 1 : 200; anti-SC-35 mAb (provided by Dr Tom Maniatis, Harvard University) 1 : 2; anti-Pol II mAb (Promega Corp., Madison, Wisconsin) 1 : 1000; anti-FLAG mAb (International Biotechnologies Inc., New Haven, Connecticut), 1 : 100; anti-adenovirus DPB mAb (clone B6-10, provided by Dr Eileen Bridge, Uppsala University, Sweden but originally from Reich et al., 1983 , 1 : 100; and anti-PML antiserum (provided by Dr Ronald Evans, The Salk Institute for Biological Studies, La Jolla, California), 1 : 1000. After washing, slides were incubated for 45 min with appropriate,¯uorochrome-conjugated secondary antibodies (Caltag Laboratories, South San Francisco, California) diluted 1 : 500 in blocking solution. Finally, slides were washed for 10 min in PBS, mounted using a solution of glycerol and p-phenylenediamine, examined by¯uorescence microscopy and photographed. Thirty-®ve millimeter projection slides were digitized using a Sony model XC77 CCD video camera solely to facilitate cropping, labeling and aligning of Figures.
In situ detection of nascent transcripts and DNA replication centres
In situ detection of nascent transcripts was carried out essentially as described (Wansink et al., 1993) . Brie¯y, transfected COS-7 cells growing on gelatinized coverslips were washed in Tris-buered saline (TBS; NaCl, 150 mM; Tris-HCl pH 7.4, 10 mM; MgCl 2 , 5 mM) and then brie¯y in glycerol buer (Tris-HCl pH 7.4, 20 mM; MgCl 2 , 5 mM; glycerol, 25%; PMSF, 0.5 mM; EGTA, 0.5 mM). Cells were permeabilized by incubation for 3 min in glycerol buer containing 0.05% Triton X-100 and run-on transcription was carried out by incubation for 10 ± 30 min in transcription buer (KCl, 100 mM; Tris-HCl pH 7.4, 50 mM; MgCl 2 , 5 mM; EGTA, 0.5 mM; glycerol, 25%; RNAse inhibitor from human placenta (Boehringer Mannheim), 5 U/ml; PMSF, 1 mM; ATP, CTP and GTP, 0.5 mM each; BrUTP, 0.2 mM). Cells were washed brie¯y in TBS containing 0.5% Triton X-100 and 5 U/ml RNAse inhibitor, washed brie¯y in TBS containing RNAse inhibitor and then ®xed for 10 min in 3.7% formaldehyde in PBS. Labeled transcripts were detected by immuno¯uorescence using 5 mg/ml of a monoclonal antibody against BrdU that cross-reacts with BrU (Boehringer Mannheim). No signal was observed when transcription reactions were run in the absence of BrU or the presence of actinomycin D.
The method used for detection of DNA replication centres was based on a previously-published protocol (Tischler et al., 1992) . Transfected COS-7 cells growing on coverslips were labeled with BrdU, 10 mM in complete culture medium for 10 ± 30 min. The coverslips were washed in PBS and ®xed in 90% ethanol for 10 min. Cells were re-hydrated in PBS and incubated for 30 min in blocking solution containing anti-E47 antiserum to detect E2A-PBX1b. After a brief wash in PBS and ®xation in 3.7% formaldehyde for 15 min, cells were incubated for 60 min at 378C in PBS (containing Mg 2+ and Ca 2+ ); DNAseI, 50 mg/ml; anti-BrdU mAb, 5 mg/ml; Triton X-100, 0.5%; and BSA, 3%. Subsequent steps for immuno¯uorescence detection were as described above.
